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Abstract
Introduction: To assess the effectiveness of early unilateral laparoscopic adrenalectomy in ACTH-independent and subclinical hypercor-
tisolaemia. 
Material and methods: We conducted a unicentric, retrospective study. Between 2010 and 2015, 356 laparoscopic adrenalectomies were 
performed in the Department of General and Endocrine Surgery of the MUW. Hypercortisolaemia was found in 50 (14%) patients, while 
overt hypercortisolaemia was found in 31 patients. In the hypercortisolaemia group, ACTH-dependent hypercortisolaemia was diagnosed 
in five (10%) and ACTH-independent hypercortisolaemia in 25 patients (50%). One patient with overt hypercortisolaemia had cancer 
of the adrenal cortex. The remaining 19 (38%) patients had subclinical Cushing’s syndrome. For our study, we compared patients with 
ACTH-independent hypercortisolaemia (n = 25) with those with Cushing’s syndrome (n = 19). Patients with ACTH-dependent hyper-
cortisolaemia (n = 5) and the patient with cancer of the adrenal cortex (n = 1) were excluded. 
Results: Patients from both groups (n = 44) underwent a unilateral transperitoneal adrenalectomy. Good early outcomes were observed 
in 42 patients (93.3%). In one patient, an additional laparoscopic surgery was necessary on postoperative day 0 due to bleeding. In another 
patient, on day 22 post-surgery, we found an abscess in the site of the excised adrenal gland, which was drained under laparoscopic guid-
ance. In three patients (6.8%) with substantial obesity, temporary respiratory insufficiency of varying degrees occurred. We did not observe 
any thromboembolic complications. All patients with overt hypercortisolaemia and nine patients with subclinical hypercortisolaemia had 
secondary adrenal insufficiency postoperatively. 
Conclusions: Transperitoneal unilateral laparoscopic adrenalectomy is an efficient and safe treatment option in patients with ACTH- 
-independent hypercortisolaemia, both overt and subclinical. (Endokrynol Pol 2018; 69 (4): 411–415)
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Streszczenie
Wstęp: Celem pracy była ocena skuteczności wczesnej jednostronnej adrenalektomii laparoskopowej w niezależnej od ACTH i subkli-
nicznej hiperkortyzolemii.
Materiał i metody: Przeprowadzono jednoośrodkowe, retrospektywne badanie. W latach 2010–2015 wykonano 356 adrenalektomii 
laparoskopowych w Klinice Chirurgii Ogólnej i Endokrynologicznej Warszawskiego Uniwersytetu Medycznego (WUM). Hiperkortyzo-
lemię stwierdzono u 50 pacjentów (14%), natomiast jawną hiperkortyzolemię u 31 pacjentów. W grupie pacjentów z hiperkortyzolemią, 
hiperkortyzolemię ACTH-zależną zdiagnozowano u pięciu (10%) pacjentów, natomiast ACTH-niezależną u 25 (50%) pacjentów. U jednego 
z pacjentów z jawną hiperkortyzolemią stwierdzono raka kory nadnerczy. U pozostałych 19 (38%) pacjentów stwierdzono subkliniczny 
zespół Cushinga. Dla celów niniejszego badania, porównano pacjentów z ACTH-niezależną hiperkortyzolemią (n = 25) z pacjentami 
z zespołem Cushinga (n = 19). Z badania zostali wykluczeni pacjenci z ACTH-zależną hiperkortyzolemią (n = 5) oraz pacjent z rakiem 
kory nadnerczy (n = 1).
Wyniki: Pacjentów z obu grup (n = 44) poddano jednostronnej adrenalektomii przezotrzewnowej. Dobre wczesne wyniki leczenia zaob-
serwowano u 42 pacjentów (93,3%). U jednego z pacjentów konieczna była dodatkowa operacja laparoskopowa z powodu krwawienia 
w 0. dobie pooperacyjnej. U innego pacjenta, w 22. dobie pooperacyjnej, wykryto ropień w miejscu wyciętego gruczołu nadnerczowego, 
Sadegh Toutounchi, Warsaw, Banacha 1a street, Department of General and Endocrine Surgery, Medical University of Warsaw; tel.: +48 
603 648 472, e-mail: tsadegh@gmail.com
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który został odsączony pod kontrolą laparoskopową. W przypadku trzech pacjentów (6,8%) ze znaczną otyłością, wystąpiła przejściowa 
niewydolność oddechowa o różnym stopniu nasilenia. Nie zaobserwowano żadnych powikłań zakrzepowo-zatorowych. U wszystkich 
pacjentów z jawną hiperkortyzolemią oraz u dziewięciu pacjentów z subkliniczną hiperkortyzolemią stwierdzono wtórną niewydolność 
nadnerczy po operacji. 
Wnioski: Jednostronna laparoskopowa adrenalektomia przezotrzewnowa jest skuteczną i bezpieczną opcją leczenia pacjentów z ACTH-
-niezależną hiperkortyzolemią, zarówno jawną jak i subkliniczną. (Endokrynol Pol 2018; 69 (4): 411–415)
Słowa kluczowe: zespół Cushinga, ACTH-niezależny zespół Cushinga, subkliniczny zespół Cushinga
Introduction
Since the pioneering work of Harvey Cushing (1869–
1939) on the physiology and pathology of the pituitary 
gland and its influence on the exocrine function of 
the adrenal cortex, a rapid development of treatment 
options for patients with associated dysfunctions has 
evolved. Most prominent, despite their rare incidence 
(2–3 individuals per million) are hypercortisolaemia, 
Cushing’s disease (CD), and Cushing’s syndrome (CS). 
Hypercortisolaemia is three times more prevalent in 
women than in men [1]. It can be endogenous or exog-
enous; the former being seen in Cushing’s syndrome, 
Cushing’s disease, and ectopic cortisol-secreting endo-
crine tumours. The latter is associated with prolonged 
glucocorticoid use (e.g. in patients with autoimmune 
diseases) [2]. The incidence of endogenous Cushing’s 
syndrome is reported as low; however, this is due to 
under-evaluation of patients with uncontrolled diabetes 
mellitus, obesity, or hypertension. Underestimation 
could be avoided by screening for Cushing’s syndrome 
in therapy-resistant diabetes or hypertension. So far, 
however, most cases of adrenal tumours still prevail as 
incidental findings on radiographies. With the rapid 
development of radiological techniques and increasing 
availability and use of these, incidentalomas are becom-
ing more frequent. Subclinical Cushing’s syndrome has 
been reported in 5–10% of these patients. 
Symptoms of hypercortisolaemia — obesity, hyper-
tension, diabetes, hyper- and dyslipidaemia, osteopo-
rosis, etc. — often impair the quality of life, which is 
especially abominable in patients with unrecognised 
long-term hypercortisolaemia [3]. There is even a corre-
lation proven between hypercortisolaemia and depres-
sion. Laparoscopic adrenalectomy (LA) has emerged 
as the golden standard of care for cortisol-producing 
adrenal adenomas < 5 cm and has overruled open 
adrenalectomy (OA). Also, recent studies reported LA 
to be beneficial in patients with subclinical Cushing’s 
syndrome, leading to a reduction of life-impacting 
symptoms, such as arterial blood pressure, and in-
creased body weight and fasting glucose levels. Thus, 
there is a need to validate the trend of performing LA 
as symptomatic treatment for ACTH-independent hy-
percortisolaemia and subclinical Cushing’s syndrome 
— the disease variants where standard drug treatment 
is not effective and a laparotomic surgery approach is 
too radical. 
While LA is recommended for cortisol-producing 
adrenal adenomas < 5 cm, there is, however, contro-
versy in the surgical field of whether LA is also safe for 
large tumours. Data on specifically large tumour LA 
are scarce and so it remains to the surgeons’ discretion 
which approach (LA or OA) is chosen. Whether LA is 
a safe and efficient therapeutic approach for patients 
with adrenal tumours > 5 cm and ACTH-independent 
hypercortisolaemia and subclinical Cushing’s syndrome 
is also still unclear. One of the mostly feared complica-
tions is postoperative hypocortisolism; therefore, data 
with long-term follow-up are imperative.
The aim of our retrospective, unicentric, long-term 
follow-up study, was to address those knowledge gaps 
and assess the safety and the effectiveness of laparo-
scopic adrenalectomy as a treatment of hypercortisol-
aemia in specific subgroups of ACTH-independent hy-
percortisolaemia and subclinical Cushing’s syndrome, 
with tumours smaller and larger than 5 cm. 
Material and methods 
We retrospectively analysed outcomes of laparoscopic 
adrenalectomies performed between 2010 and 2015 in 
the Department of General and Endocrine Surgery, 
MUW, in patients with clinically and biochemically 
confirmed hypercortisolaemia (preoperatively, all pa-
tients underwent an endocrine work-up). Of a total of 
356 laparoscopic adrenalectomies performed due to 
adrenal tumours, 147 (41.3%) specimens were positive 
for adenomatous hyperplasia or individual adrenal cor-
tical adenomas in histopathological findings. Of those, 
50 patients (34%) had confirmed hypercortisolaemia/ 
/Cushing’s syndrome (CS): 39 (78%) women and 11 
(22%) men, aged 28–72 years (mean: 48.7 years). Five 
patients (10%) had ACTH-dependent hypercortisolae-
mia, 26 (52%) patients ACTH-independent hypercor-
tisolaemia, and the remaining 19 (38%) patients had 
subclinical Cushing’s syndrome. Typical symptoms 
in the studied group included hypertension (40 pa-
tients, 90.9%), obesity (25, 56.8%), and type 2 diabetes 
(23, 52.3%). In all cases, the presence of tumours was 
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confirmed preoperatively on radioimaging (US, CT, 
MRI, PET); the tumour size ranged from 23 to 90 mm 
(mean 36 mm) and the density between 5 and 30 jH. 
In 13 (29.5%) patients, we found bilateral adrenal en-
largement (adrenal thickness > 10 mm). 
Overt hypercortisolaemia was defined as the pres-
ence of typical symptoms — hypertension, obesity, dia-
betes, osteoporosis, depression — confirmed by at least 
two screening tests (short dexamethasone suppression 
test, urine free cortisol excretion, or late-night saliva or 
serum cortisol). ACTH-independent hypercortisolaemia 
was diagnosed at ACTH levels < 5 pg/mL, and ACTH-
dependent hypercortisolaemia was diagnosed at ACTH 
levels > 20 pg/mL. Subclinical hypercortisolaemia was 
diagnosed in patients without evident symptoms, while 
the cortisol level in the dexamethasone suppression test 
was > 5 mg/dL and the level of ACTH was < 5 pg/mL.
All surgeries were performed under general an-
aesthesia, using a transperitoneal approach with four 
ports. Trocars were introduced along the costal margin, 
starting from the midline to the tip of rib XII, on both 
sides. Dissection was performed with a harmonic knife, 
and a simple retractor was used to create a triangular 
operating field that allowed for mobilisation of the liver, 
spleen, and pancreatic tail in the peritoneal space. Fol-
lowing clipping of the adrenal arteries and veins, the 
adrenal gland was removed from the peritoneal cavity 
with a laparoscopic bag. In six patients with large tu-
mours (diameter > 50 mm), we enlarged the entrance 
site for trocars in the abdominal wall (mini-laparotomy), 
which was then stitched up. Cortisol levels were meas-
ured in all patients on postoperative day 0, 10 hours 
after the intervention. Depending on the cortisol level, 
hydrocortisone substitution for a mean period of two 
weeks was administered. At cortisol level < 5 mg/dL, 
hydrocortisone was given at a dose of 20–30 mg daily. 
For the statistics, analysis of interest data distribu-
tion in both groups was conducted with Fisher Exact 
Test. All calculations were performed with the package 
Statistica 13.0. 
Results
All patients underwent laparoscopic transperitoneal 
adrenalectomy; conversion to open surgery was not 
necessary in any case. We analysed early treatment 
outcomes in a total of 44 patients: in patients with 
subclinical Cushing’s syndrome (n = 19, 43.2%) and in 
patients with ACTH-independent hypercortisolaemia 
(n = 25, 56.8%). In the first group (subclinical Cushing’s 
syndrome), tumour size ranged from 8 x 33 mm to 67 
x 72 mm (mean: 26 x 42 mm), as measured on CT, MRI, 
US, or postoperative samples. The mean tumour size in 
patients with ACTH-independent hypercortisolaemia 
was 30 x 38 mm. Thirteen patients (29.5%) who had 
a subtle enlargement of the contralateral adrenal gland 
preoperatively (thickness greater than 10 cm, i.e. twice 
the normal size) were followed up on an outpatient 
basis Surgery duration ranging from 75 min to 210 min 
(mean: 130 min). We performed right adrenalectomy in 
20 (45.5%) patients and left adrenalectomy in 24 (54.5%) 
patients. In the ACTH-independent hypercortisolaemia 
group, secondary adrenal insufficiency appeared signif-
icantly more often (p < 0.0001). Further characteristics 
on the surgeries and the postoperative period for both 
groups are presented in Table I. 
In the postoperative period, only two patients 
(4.5%) needed a further intervention: one patient due 
to a bleeding and one patient due to an abscess in the 
excised adrenal gland. Bleeding from the adrenal area 
was stopped laparoscopically with a fibrin sealant (TIS-
SEL). The abscess in the site of the excised adrenal gland 
(left) was drained laparoscopically. 
In the postoperative period, subacute respiratory 
insufficiency with dyspnoea and fever (up to 38oC) oc-
curred in three obese patients. Radiographically, these 
Table I. Characteristics of the laparoscopic transperitoneal 
adrenalectomy the postoperative period of patients with 
ACTH-independent hypercortisolaemia and with subclinical 
hypercortisolaemia
Tabela I. Charakterystyka laparoskopowej adrenalektomii 
przezotrzewnowej i okresu pooperacyjnego u pacjentów 
z ACTH-niezależną hiperkortyzolemią i subkliniczną 
hiperkortyzolemią
Side ACTH-
independent 
CS
Subclinical 
CS
P
Mean surgery 
duration (min)
Right 120 90 Insignificant
Left 150 126 Insignificant
Bleeding/blood 
transfusions 
Right x x Insignificant
Left x 1 Insignificant
Use of haemostatic 
glue 
Right x x Insignificant
Left 1 3 Insignificant
Suppurative 
complications 
Right x x Insignificant
Left 1 x Insignificant
Number of 
conversions 
x x Insignificant
Number of  
re-operations 
2 x Insignificant
Respiratory 
insufficiency 
3 x Insignificant
Thromboembolic 
complications 
x x Insignificant
Secondary 
adrenal 
insufficiency 
25 9 P < 0.0001
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episodes were associated with atelectasis in the lower 
lung lobes. Respiratory rehabilitation and antibiotics led 
to complete symptom resolution. All patients enrolled 
in the study received thromboembolic prophylaxis with 
low-molecular-weight heparin and graduated compres-
sion stockings. The duration of follow-up in both groups 
was similar, ranging from two to four weeks. Table II 
summarises the leading symptoms and diagnostic 
parameters in patients with ACTH-independent hy-
percortisolaemia and subclinical Cushing’s syndrome. 
Strikingly, diabetes appears significantly more often in 
patients treated for subclinical Cushing’s syndrome.
Discussion
Hypercortisolaemia occurs rarely, usually as part of 
Cushing’s diseases or Cushing’s syndrome. Based on 
epidemiological studies, its incidence is slightly higher 
than one per million. More commonly, hypercortisol-
aemia is found in patients with incidentally detected 
adrenal tumours on imaging studies performed for 
other indications. Notably, hypercortisolaemia causes 
approximately 1% of secondary hypertension cases 
and is found in over 5% of patients with obesity, 
hypertension, and osteoporosis [1, 4, 5]. Among pa-
tients treated for adrenal tumours in our centre, we 
detected hypercortisolaemia in only 14% of cases. The 
ratio of overt ACTH-dependent hypercortisolaemia 
to ACTH-independent and subclinical hypercorti-
solaemia was 1:9. 
Thus far, literature acknowledges adrenalectomy, in-
cluding the least invasive, laparoscopic approach, as the 
golden standard with therapeutic benefits in patients 
with CS [6, 7]. Unilateral laparoscopic adrenalectomy 
is associated with good long-term outcomes in over 
80% of CS patients. However, there is a risk of hyper-
cortisolaemia recurrence, commonly in patients with 
contralateral adrenal gland enlargement preoperatively 
or on follow-up [8, 9, 10]. In our study, a slight enlarge-
ment of the contralateral adrenal gland was found in 
as many as 13 patients. According to our protocol, we 
removed significantly enlarged adrenal glands and 
monitored for recurrence of hypercortisolaemia on 
follow-up. Based on long-term observation (several 
years postinterventionally), recurrence of hypercor-
tisolaemia was rarely detected. When the recurrence 
occurred, the contralateral adrenal gland was also re-
moved. Such an approach is justified by other studies, 
and our results correlate with those indicating that, in 
the long-term, recurrence of hypercortisolaemia after 
unilateral adrenalectomy is seen in approximately 20% 
of patients [11, 12]. 
All patients in our centre underwent unilateral 
transperitoneal adrenalectomy, and conversion to open 
surgery was not necessary in any patient. In one patient 
(2.3%), we observed sustained bleeding post surgery, 
which was stopped laparoscopically. In another patient 
(2.3%), on day 22 post surgery, we laparoscopically 
drained an abscess that had formed in the site of the 
excised adrenal gland. Respiratory complications were 
the most frequent ones (three patients, 6.8%), which 
correlated radiographically with atelectasis of the lower 
pulmonary lobes and pneumonia. These complications 
developed in patients with ACTH-independent hyper-
cortisolaemia and substantial obesity and older age. 
Possibly due to the strictly conducted antithrombotic 
prophylaxis, we did not record any thromboembolic 
complications. The antithrombotic prophylaxis in-
cluded low-molecular-weight heparin (1 mg/kg) and 
graduated compression stockings during the surgery. 
Patients with hypercortisolaemia are at an increased 
risk of thromboembolic complications due to the direct 
pro-thrombotic effects of cortisol and other indirect pro-
thrombotic effects caused by cortisol-related metabolic 
derangements. Another factor that increases the risk of 
thromboembolic complications is compression of large 
veins due to pneumothorax related to laparoscopic 
adrenalectomy [13, 14]. 
Our results also further correlate with other reports 
stating that the general morbidity following laparo-
scopic adrenalectomy ranges from 0 to 8% [9] and 
conversion to open surgery occurs in 2–4.2% of cases 
[7, 15]. Limiting factors in our study were the small 
sample size (although bigger than in studies so far) and 
Table II. Symptoms and diagnostic parameters in patients 
with ACTH-independent hypercortisolaemia and subclinical 
Cushing’s syndrome
Tabela II. Objawy i parametry diagnostyczne pacjentów 
z ACTH-niezależną hiperkortyzolemią i subklinicznym 
zespołem Cushinga
Symptoms ACTH-
independent 
Cushing’s 
syndrome
Subclinical 
Cushing’s 
syndrome
Total P
Diabetes 8 15 23 P < 0.003
Hypertension 23 17 40 Insignificant
Obesity 15 10 25 Insignificant
Depression 4 2 6 Insignificant
Tumour size on 
CT [mm]
35 x 42 32 x 46 Insignificant
Adenoma* 14 12 26 Insignificant
Adenomatous 
hyperplasia*
11 7 18 Insignificant
Cancer of 
adrenal cortex 
1 0 1 Insignificant
*based on histopathology
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the retrospective character. Our results are enforced 
by the long follow-up, which meant that long-term 
complications could be recorded. Further prospective 
studies are warranted.
Conclusions
Laparoscopic adrenalectomy is an efficient, safe, and 
effective curative approach for adrenal tumours in 
patients with ACTH-independent hypercortisolaemia 
and subclinical Cushing’s syndrome. The symptoms can 
mostly be eliminated permanently, while the compli-
cation rate and duration of hospitalisation is low. The 
approach can be implemented with the same success 
and safety profile to large tumours > 5 cm. 
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